Nectar Lifescience secures ANVISA (Brazil) cGMP

For Cephalosporin API's manufacturing facility

Nectar Lifescience has received ANVISA cGMP (current good manufacturing practices) approval for Brazil for its Cephalosporin API's manufacturing facility in Dera Bassi, Punjab.

Powered by Capital Market - Live News